Molecular Medicine Reports · 2018 · 20 citations · 19 references
MedicineMolecular BiologyOncologyBreast OncologyGene ExpressionMolecular OncologyApoptosis ResistanceMicrorna BiologyMicrorna-mediated RegulationNoncoding Rna In CancerRna InterferenceSignal Transduction In CancerBreast Cancer Resistance MechanismsCancer Cell ApoptosisMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna-mediated Apoptosis ControlMicrorna-mediated ResistanceTumor Cell Proliferation
Breast cancer is the second leading cause of cancer‑associated mortalities in women. Tamoxifen (TAM) is an endocrine therapy commonly used in the treatment of patients with breast cancer expressing estrogen receptor α. However, treatment often ends in failure due to the emergence of drug resistance. MicroRNAs (miRNAs), a family of small non‑coding RNAs, serve critical roles in the regulation of gene expression and cell events. To date, whether miRNA‑663b could mediate TAM resistance in breast cancer remains unknown. Therefore, the aim of the present study was to investigate the role of miRNA‑663b in TAM resistance in breast cancer. The results demonstrated that miRNA‑663b was upregulated in breast cancer with TAM resistance. Tumor protein 73 (TP73) was a direct target of miRNA‑663b, and was negatively regulated by miRNA‑663b in MCF‑7 cells. Furthermore, it was identified that downregulation of miRNA‑663b inhibited cell proliferation ability and promoted cell apoptosis, resulting in enhanced TAM sensitivity. In addition, these findings suggested that TP73 silencing may have eliminated the effects of miRNA‑663b inhibitor on breast cancer cells. In conclusion, the present study verified a novel molecular link between miRNA‑663b and TP73, and indicated that miRNA‑663b may be a critical therapeutic target in breast cancer.
19
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Marilena V. Iorio, Manuela Ferracin, Chang‐Gong Liu et al. · Cancer Research · 2005 · 4.1K citations
Maya Gutierrez, Simone Detre, Stephen Johnston et al. · Journal of Clinical Oncology · 2005 · 489 citations · Full text
Medicine, Cancer Biology, Oncology +15